Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 3
2004 3
2006 1
2008 3
2009 1
2010 2
2011 2
2012 3
2013 1
2014 1
2015 1
2016 1
2018 2
2019 1
2020 1
2021 2
2022 3
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab-combination therapy for NSCLC- effectiveness and predictive factors in real-world practice.
Knetki-Wróblewska M, Dziadziuszko R, Jankowski T, Krawczyk P, Bryl M, Stencel K, Wrona A, Bandura A, Smok-Kalwat J, Rok-Knapińska J, Szydziak-Zwierzyńska K, Rogoziewicz K, Czyżewicz G, Wójtowicz M, Wojtukiewicz M, Kalinka E, Wysocki PJ, Łobacz M, Milanowski J, Pawlik H, Kowalski DM, Krzakowski M. Knetki-Wróblewska M, et al. Among authors: wysocki pj. Front Oncol. 2024 Jan 23;14:1341084. doi: 10.3389/fonc.2024.1341084. eCollection 2024. Front Oncol. 2024. PMID: 38322415 Free PMC article.
The Impact of Sidedness on the Efficacy of Anti-EGFR-Based First-Line Chemotherapy in Advanced Colorectal Cancer Patients in Real-Life Setting-A Nation-Wide Retrospective Analysis (RACER).
Potocki PM, Wiśniowski R, Haus D, Chowaniec Z, Kozaczka M, Kustra M, Samborska-Plewicka M, Szweda M, Starzyczny-Słota D, Michalik M, Słomian G, Lebiedzińska A, Jonak-Olczyk N, Łaszewska-Kraińska N, Adamowicz K, Kolenda P, Drosik-Kwaśniewska A, Szwiec M, Dziura R, Czech J, Dąbrowska M, Nowakowska-Zajdel E, Klank-Sokołowska E, Konopka K, Kwinta Ł, Dobrzańska J, Wysocki PJ. Potocki PM, et al. Among authors: wysocki pj. Cancers (Basel). 2023 Sep 1;15(17):4361. doi: 10.3390/cancers15174361. Cancers (Basel). 2023. PMID: 37686636 Free PMC article.
Capivasertib in Hormone Receptor-Positive Advanced Breast Cancer.
Turner NC, Oliveira M, Howell SJ, Dalenc F, Cortes J, Gomez Moreno HL, Hu X, Jhaveri K, Krivorotko P, Loibl S, Morales Murillo S, Okera M, Park YH, Sohn J, Toi M, Tokunaga E, Yousef S, Zhukova L, de Bruin EC, Grinsted L, Schiavon G, Foxley A, Rugo HS; CAPItello-291 Study Group. Turner NC, et al. N Engl J Med. 2023 Jun 1;388(22):2058-2070. doi: 10.1056/NEJMoa2214131. N Engl J Med. 2023. PMID: 37256976 Clinical Trial.
Metronomic Chemo-Endocrine Therapy (FulVEC) as a Salvage Treatment for Patients with Advanced, Treatment-Refractory ER+/HER2-Breast Cancer-A Retrospective Analysis of Consecutive Patients Data.
Buda-Nowak A, Kwinta Ł, Potocki P, Michałowska-Kaczmarczyk A, Słowik A, Konopka K, Streb J, Koniewski M, Wysocki PJ. Buda-Nowak A, et al. Among authors: wysocki pj. J Clin Med. 2023 Feb 8;12(4):1350. doi: 10.3390/jcm12041350. J Clin Med. 2023. PMID: 36835886 Free PMC article.
Metronomic Chemotherapy in Prostate Cancer.
Wysocki PJ, Lubas MT, Wysocka ML. Wysocki PJ, et al. J Clin Med. 2022 May 18;11(10):2853. doi: 10.3390/jcm11102853. J Clin Med. 2022. PMID: 35628979 Free PMC article. Review.
Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trial.
Powles T, Yuen KC, Gillessen S, Kadel EE 3rd, Rathkopf D, Matsubara N, Drake CG, Fizazi K, Piulats JM, Wysocki PJ, Buchschacher GL Jr, Alekseev B, Mellado B, Karaszewska B, Doss JF, Rasuo G, Datye A, Mariathasan S, Williams P, Sweeney CJ. Powles T, et al. Among authors: wysocki pj. Nat Med. 2022 Jan;28(1):144-153. doi: 10.1038/s41591-021-01600-6. Epub 2022 Jan 10. Nat Med. 2022. PMID: 35013615 Free PMC article. Clinical Trial.
38 results